Cann Group Limited (CNGGF)

Market Cap	4.67M -21.8%
Revenue (ttm)	7.54M -27.1%
Net Income	9.83M
EPS	0.01
Shares Out	n/a
PE Ratio	0.48
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,500
Open	0.0015
Previous Close	n/a
Day's Range	0.0015 - 0.0015
52-Week Range	0.0015 - 0.0278
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 4, 2026

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Country: Australia
• Stock Exchange: OTCMKTS
• Ticker Symbol: CNGGF

Financial Performance

In fiscal year 2025, Cann Group's revenue was 13.25 million, a decrease of -27.81% compared to the previous year's 18.36 million. Losses were -22.35 million, -56.39% less than in 2024.

Financial numbers in AUD